Tue, February 21, 2017
Mon, February 20, 2017
Fri, February 17, 2017

Kennen MacKay Initiated (ANAB) at Buy and Held Target at $34 on, Feb 21st, 2017

Kennen MacKay of Credit Suisse, Initiated "AnaptysBio, Inc." (ANAB) at Buy and Held Target at $34 on, Feb 21st, 2017.

Kennen, nor any peers, have made any analyst calls on ANAB in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30